Concepedia

Extensive environmental contamination and prolonged severe acute respiratory coronavirus-2 (SARS CoV-2) viability in immunosuppressed recent heart transplant recipients with clinical and virologic benefit with remdesivir

Irina Rajakumar, Debra Isaac, Nowell M. Fine, Brian Clarke, Linda Ward, Rebecca J. Malott, Kanti Pabbaraju, Kara Gill, Byron M. Berenger, Yi-Chan Lin,

Infection Control and Hospital Epidemiology · 2021 · 15 citations · 7 references

DOIFull text

Open access

Concepts

Abstract

Extensive environmental contamination and prolonged severe acute respiratory coronavirus-2 (SARS CoV-2) viability in immunosuppressed recent heart transplant recipients with clinical and virologic benefit with remdesivir - Volume 43 Issue 6

References

7

Remdesivir for the Treatment of Covid-19 — Final Report

John H. Beigel, Kay M Tomashek, Lori E. Dodd et al. · New England Journal of Medicine · 2020 · 7.7K citations · Full text

, , +15

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

New England Journal of Medicine · 2020 · 2.6K citations · Full text

, , +16

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

Calvin J. Gordon, Egor P. Tchesnokov, Emma Woolner et al. · Journal of Biological Chemistry · 2020 · 1K citations · Full text

, , +16

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2

Brandi N. Williamson, Friederike Feldmann, Benjamin Schwarz et al. · Nature · 2020 · 740 citations · Full text

, , +14

Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient

Ji Hoon Baang, Christopher Smith, Carmen Mirabelli et al. · The Journal of Infectious Diseases · 2020 · 336 citations · Full text

, , +17